Jean S Lynch

Title: The Innovative Contributions of Jean S. Lynch in Organic Anion Transport Proteins

Introduction: Jean S. Lynch is a distinguished inventor based in Ringoes, New Jersey, recognized for his significant contributions to the field of organic anion transport proteins. With a total of three patents to his name, Lynch's work focuses on the development of novel proteins that play essential roles in drug targeting and substrate modulation.

Latest Patents: Among his latest inventions, Lynch has disclosed nucleic acid and amino acid sequences for innovative organic anion transfer proteins (OATPs). These inventions not only encompass the OATPs described but also include vectors containing the cDNA sequences, host cells containing these vectors, and polypeptides that may possess all or parts of an OATP. Furthermore, the applications of these OATPs extend to targeting drugs to specific organs and modulating the concentration of endogenous substrates, showcasing their potential in therapeutic strategies.

Career Highlights: Jean S. Lynch is currently employed at Bristol-Myers Squibb Company, where he has continued to push the boundaries of research and innovation. His expertise in molecular biology and protein engineering has made a significant impact on the development of targeted therapies.

Collaborations: Throughout his career, Lynch has collaborated with talented colleagues, including Todd G. Kirchgessner and Bonnie Hsiang. These collaborations have contributed to the advancement of knowledge and the development of breakthrough innovations in the pharmaceutical industry.

Conclusion: Jean S. Lynch’s work embodies the spirit of innovation in the biomedical field. His patents in organic anion transport proteins not only highlight his expertise but also reflect the collaborative nature of scientific research, paving the way for potential advancements in therapeutic applications.